Troy A. Ignelzi - 06 Jan 2022 Form 3 Insider Report for CinCor Pharma, Inc.

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 19:57:18 UTC
Previous filing
22 Dec 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CINC Stock Option (Right to Buy) 06 Jan 2022 Common Stock 36,324 $5.82 Direct F1
holding CINC Stock Option (Right to Buy) 06 Jan 2022 Common Stock 58,823 $13.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments over a three-year period measured from one year following May 17, 2021, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
F2 This option vests in equal annual installments over a three-year period measured from one year following December 10, 2021, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney